DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Sargramostim
Sargramostim
Therapeutic Class Overview Colony Stimulating Factors
Sargramostim (Leukine®)
Regenerative Mechanisms and Novel Therapeutic Approaches
Sargramostim (Leukine) Reference Number: CP.PHAR.295 Effective Date: 12/16 Coding Implications Last Review Date: 10/16 Revision Log
Autoimmune Pulmonary Alveolar Proteinosis in an Adolescent Successfully Treated with Inhaled Rhgm-CSF
Leukine® (Sargramostim)
Colony Stimulating Factors Medical Policy
Leukine (Sargramostim)
New Therapeutic Options in the Medical Management of Advanced Melanoma Jose Lutzky, MD, FACP
Colony Stimulating Factors
Mobilization of Peripheral Blood Stem Cells Following Myelosuppressive Chemotherapy: a Randomized Comparison of Filgrastim, Sarg
Pharmacology of Recombinant Or Genetically Engineered Drugs
Soluble Prokaryotic Overexpression and Purification of Human GM-CSF Using the Protein Disulfide Isomerase B'a' Domain
Differentiating Neuroblastoma: a Systematic Review of the Retinoic Acid, Its Derivatives, and Synergistic Interactions
Evaluation of Effectiveness of Granulocyte-Macrophage Colony-Stimulating Factor Therapy to Cancer Patients After Chemotherapy: a Meta-Analysis
Recommendations for the Use of White Blood Cell Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
Are All Gfs Equal? How Say I?
Top View
White Blood Cell Colony Stimulating Factors – Value & Balance Exchange Medical Benefit Drug Policy
Production Design of Efficient Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor Under a Gene-Specific Promoter in Prokaryotic System
Effects of GM-CSF on Dendritic Cells and Regulatory T Cells in Parkinson’S Disease Patients and Models of Parkinson’S Disease
The Impact of Biosimilar Competition June 2016 the Impact of Biosimilar Competition Introduction
Treatment of Metastatic Uveal Melanoma: Systematic Review
White Blood Cell Growth Factors
Colony Stimulating Factors - Leukine® (Sargramostim Injection)
How I Treat Patients Who Mobilize Hematopoietic Stem Cells Poorly
The Impact of Biosimilar Competition in Europe Contents
Ipilimumab Plus Sargramostim Vs Ipilimumab Alone
A Phase I Study of Recombinant Human Leukemia Inhibitory Factor in Patients with Advanced Cancer1
TCR Template
Synthesis of Granulocyte–Macrophage Colony- Stimulating Factor As Homogeneous Glycoforms and Early Comparisons with Yeast Cell-Derived Material
Colony Stimulating Factors
HEMATOPOIETIC AGENTS;GROWTH FACTORS,MINERALS and VITAMINS Phr.Volkan KAHRAMAN HGF’S
Pegfilgrastim), Leukine® (Sargramostim), Granix (Tbo-Filgrastim
Sargramostim
United States Patent (19) 11 Patent Number: 5,670477 Poduslo Et Al
Study Protocol and Statistical Analysis Plan
Generic-To-Trade Names
103362Orig1s5240
Human GM-CSF ELISA Kit (ARG80122)
Cytokines (CHO-Expressed)
LEUKINE® (Sargramostim)
Cost-Effectiveness and Budgetary Impact of Lipegfilgrastim for The
Romiplostim (Nplate ) As an Effective Radiation Countermeasure to Improve Survival and Platelet Recovery in Mice
Please Refer to Figure 3 in Main Manuscript
Rat GM-CSF ELISA Kit (ARG81282)
Colony Stimulating Factors: Leukine® (Sargramostim)
Update #06 ALLIANCE for CLINICAL TRIALS IN
LEUKINE (Sargramostim) RATIONALE for INCLUSION in PA PROGRAM
Not All Hematopoietic Growth Factors Are Created Equal: Should We Gain Information for Their Use with Immunotherapy?
Versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
STEM CELL BIOLOGY and HEMATOPOIETIC GROWTH FACTORS David J
1 Poll Everywhere Audience Response Disclosures